| __timestamp | Novavax, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19928000 | 24518692 |
| Thursday, January 1, 2015 | 30842000 | 19886580 |
| Friday, January 1, 2016 | 46527000 | 12631689 |
| Sunday, January 1, 2017 | 34451000 | 21977998 |
| Monday, January 1, 2018 | 34409000 | 20759000 |
| Tuesday, January 1, 2019 | 34417000 | 20838000 |
| Wednesday, January 1, 2020 | 145290000 | 121812000 |
| Friday, January 1, 2021 | 298358000 | 152137000 |
| Saturday, January 1, 2022 | 488691000 | 83231000 |
| Sunday, January 1, 2023 | 468946000 | 122706000 |
Cracking the code
In the competitive world of biotechnology, managing expenses is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Novavax, Inc. from 2014 to 2023. Over this period, Novavax's SG&A expenses surged by over 2,200%, peaking in 2022, reflecting its aggressive expansion and marketing strategies. In contrast, TG Therapeutics saw a more modest increase of around 400%, with a notable spike in 2021. This divergence highlights different strategic approaches: while Novavax invested heavily in scaling operations, TG Therapeutics maintained a more conservative expenditure. Understanding these trends offers insights into each company's operational priorities and market positioning. As the biotech landscape evolves, monitoring such financial metrics can provide valuable foresight into future industry shifts.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Incyte Corporation and Novavax, Inc.
Catalent, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Walgreens Boots Alliance, Inc. vs TG Therapeutics, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Novavax, Inc.
Operational Costs Compared: SG&A Analysis of Madrigal Pharmaceuticals, Inc. and TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for TG Therapeutics, Inc. and Amicus Therapeutics, Inc.
TG Therapeutics, Inc. or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
Xencor, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared